Meda said today it will buy Rottapharm Madaus for SEK 21.2 billion (about $3.1 billion) from Italy's Rovati family, in a deal the buyer said reflected its desire to grow into a leading specialty pharma through acquisitions—namely by combining the ... Genetic Engineering News, 13 hours ago
The medicines watchdog, the Health Products Regulatory Authority (HPRA), has recommended that the migraine drug sumatriptan be made available over the counter, rather than on prescription-only as at present. The drug, which is better known under ...Irish Health.com, 1 week ago
TREATMENTS for migraine, stomach problems, hay fever, cold sores and nail infections will be made over-the-counter, meaning a patient will be able to bypass an expensive visit to their GP. The 34 products, which are currently prescription-only, will ...Irish Independent, 2 weeks ago
Shares of Cadila Healthcare recouped previous day's losses on Monday, up as much as 2.5 percent intraday as Credit Suisse maintains outperform rating on the stock and increased target price by 13 percent to Rs 1250. The brokerage says Cadila could ...Moneycontrol.com, 3 weeks ago
U (Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., June 30 -- The following federal patents were awarded to inventors in New Jersey. *** LSI Corp. Assigned Patent ALEXANDRIA, Va., June ...TMC Net, 1 month ago
Perrigo Company plc, a provider of over-the-counter and generic prescription pharmaceuticals, has received FDA approval for its abbreviated new drug application, or ANDA, for azelastine hydrochloride nasal spray, indicated for treatment of seasonal ...Individual.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!